Max Robotics — Global Service Robot Directory + US Certification

About

Stephen K. Anderson has made transformative contributions to functional genomics and antibody engineering, with a career centered on developing high-throughput tools for protein and antibody discovery. His landmark 2015 study, cited over 120 times, introduced an industrialized platform for generating recombinant antibodies to folded proteins, specifically targeting 346 transcription factors. This work addressed a critical bottleneck in biology: the lack of renewable, sequence-defined antibody reagents. By enabling scalable production of validated recombinant antibodies, Anderson’s platform has empowered researchers to study protein function with unprecedented reproducibility and permanence. His approach bridges the gap between genomics and proteomics, providing essential resources for chromatin biology and transcriptional regulation. Beyond this flagship achievement, Anderson’s broader portfolio includes innovations in protein expression, antigen design, and automation, cementing his reputation as a leader in reagent standardization. His work has not only accelerated basic research but also laid the groundwork for therapeutic antibody development. For students and researchers, Anderson exemplifies how engineering biology at scale can solve fundamental challenges in molecular biology, making his platform a cornerstone for labs seeking robust, renewable tools to decode the proteome.